Researchers in Hungary investigated the efficacy of COVID-19 boosters in patients with autoimmune rheumatic and musculoskeletal diseases. They also studied whether a SARS-CoV-2 infection following a two-dose primary series increased antibody production by the immune system in lieu of a booster.
Read More »Researchers created an online questionnaire for RA and AIRD patients to self-report short-term COVID-19 vaccine-related adverse events. Vaccines included in the study were Pfizer, Moderna, Johnson & Johnson, AstraZeneca, Covaxin, and Sinopharm. The most common coexisting autoimmune diseases were thyroid disorders, systemic lupus erythematosus (SLE) and Sjogren’s syndrome (10.0%, 2.6%, and 2.5%, respectively).
Read More »Researchers in British Columbia, Canada, conducted a retrospective cohort study with 1,105 adult patients to determine the risk of glomerular disease relapse following COVID-19 vaccination.
Read More »A survey-based study analyzed vaccination reactions and disease deterioration after SARS-CoV-2 vaccination among more than 6,000 MS patients in Germany and the United Kingdom.
Read More »